Daly Jason B.
SEC CIK 1906486 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| AMRX | Amneal Pharmaceuticals, Inc. | SVP, CLO | 35.2K | — | $5.25M | 13 | 2023-03-03 | 2026-08-11 |
Most active insiders at AMRX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Shah Nikita | EVP | — | $4.14M |
| 2 | Daly Jason B. | EVP, CLO | — | $3.77M |
| 3 | Kiely John | Dir | — | $882.0K |
| 4 | Nark Ted C | Dir | — | $586.0K |
| 5 | Autor Deborah M. | Dir | — | $450.6K |
| 6 | George Jeffrey P. | Dir | — | — |
| 7 | Patel Tushar Bhikhubhai | 10% | — | — |
| 8 | Patel Chirag K. | Pres, Co-CEO, Dir | — | — |
| 9 | Patel Gautam | Dir | — | — |
| 10 | Patel Chintu | Co-CEO, Dir | — | — |
Transactions 13
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2026-08-13 16:21 | 2026-08-11+ | AMRX | Amneal Pharmaceuticals, Inc. | Daly Jason B. | EVP, CLO | S - Sale | $17.41 | -216.6K | 35.2K | -86% | -$3.77M |
| DM | 2026-03-05 | 2026-03-03+ | AMRX | Amneal Pharmaceuticals, Inc. | Daly Jason B. | EVP, CLO | F - Tax | $13.31 | -185.6K | 58.5K | -76% | -$2.47M |
| DM | 2026-03-05 | 2026-03-03+ | AMRX | Amneal Pharmaceuticals, Inc. | Daly Jason B. | EVP, CLO | M - OptEx | — | +426.8K | 267.4K | New | — |
| 2025-08-13 | 2025-08-12 | AMRX | Amneal Pharmaceuticals, Inc. | Daly Jason B. | EVP, CLO | S - Sale | $9.05 | -22.0K | 10.6K | -67% | -$199.1K | |
| M | 2025-03-07 | 2025-03-05+ | AMRX | Amneal Pharmaceuticals, Inc. | Daly Jason B. | EVP, CLO | S - Sale | $8.80 | -90.0K | 32.6K | -73% | -$792.2K |
| DM | 2025-03-05 | 2025-03-03+ | AMRX | Amneal Pharmaceuticals, Inc. | Daly Jason B. | EVP, CLO | F - Tax | $8.78 | -64.7K | 102.3K | -39% | -$568.2K |
| DM | 2025-03-05 | 2025-03-03+ | AMRX | Amneal Pharmaceuticals, Inc. | Daly Jason B. | EVP, CLO | M - OptEx | — | +187.3K | 138.2K | New | — |
| 2024-11-22 | 2024-11-21 | AMRX | Amneal Pharmaceuticals, Inc. | Daly Jason B. | SVP, CLO | S - Sale | $8.40 | -13.7K | 0 | -100% | -$114.8K | |
| 2024-11-19 | 2024-11-15 | AMRX | Amneal Pharmaceuticals, Inc. | Daly Jason B. | SVP, CLO | S - Sale | $8.61 | -43.7K | 13.7K | -76% | -$375.9K | |
| DM | 2024-03-05 | 2024-03-03 | AMRX | Amneal Pharmaceuticals, Inc. | Daly Jason B. | SVP, CLO | M - OptEx | — | +60.9K | 68.2K | +832% | — |
| DM | 2024-03-05 | 2024-03-03 | AMRX | Amneal Pharmaceuticals, Inc. | Daly Jason B. | SVP, CLO | F - Tax | $5.47 | -18.0K | 57.3K | -24% | -$98.6K |
| D | 2023-03-07 | 2023-03-03 | AMRX | Amneal Pharmaceuticals, Inc. | Daly Jason B. | SVP, CLO | F - Tax | $1.92 | -8,164 | 14.5K | -36% | -$15.7K |
| D | 2023-03-07 | 2023-03-03 | AMRX | Amneal Pharmaceuticals, Inc. | Daly Jason B. | SVP, CLO | M - OptEx | — | +22.6K | 22.6K | New | — |
Purchase Sale Sale after option exercise All abbreviations